Literature DB >> 3883388

Impairment of vagal function in reflux oesophagitis.

A L Ogilvie, P D James, M Atkinson.   

Abstract

Autonomic nervous function in reflux oesophagitis was assessed by measuring the response of the lower oesophageal sphincter to abdominal compression, gastric secretory response to insulin-induced hypoglycaemia and pulse rate variability with respiration. Rise in intra-abdominal pressure normally causes an increase in lower oesophageal sphincter pressure through a vagally mediated mechanism. In 59 of 83 patients with reflux oesophagitis the sphincter response was subnormal, and this was commoner in older patients but was unrelated to the presence of a hiatal hernia. During oesophageal acid perfusion, the onset of pain, but not that of disordered motility, was delayed in those with an abnormal sphincter response suggesting impairment of afferent autonomic function. Efferent gastric vagal function, assessed by the gastric secretory response to insulin induced hypoglycaemia and expressed as a ratio of the maximal acid output after pentagastrin, was subnormal in 15 of 27 patients with reflux oesophagitis. Pulse rate variability with deep respiration, an indicator of one aspect of non-alimentary vagal function, was subnormal in 18 of 62 patients with reflux oesophagitis. There was no correlation between abnormalities in these three tests of vagal function or with the severity of oesophagitis. These findings suggest that vagal impairment is common in reflux oesophagitis. As impairment of vagal function is not confined to the alimentary system it is unlikely to be simply a consequence of reflux oesophagitis and may be important in the pathogenesis of gastro-oesophageal reflux.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3883388

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  16 in total

Review 1.  The autonomic nervous system in functional bowel disorders.

Authors:  G Tougas
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

2.  Gastric accommodation studied by ultrasonography in patients with reflux esophagitis.

Authors:  S Tefera; O H Gilja; J G Hatlebakk; A Berstad
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

3.  Transpyloric fluid movement and antroduodenal motility in patients with gastro-oesophageal reflux.

Authors:  P M King; A Pryde; R C Heading
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

4.  Intragastric maldistribution of a liquid meal in patients with reflux oesophagitis assessed by three dimensional ultrasonography.

Authors:  S Tefera; O H Gilja; E Olafsdottir; T Hausken; J G Hatlebakk; A Berstad
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

5.  Abnormal gastric adaptive relaxation in patients with gastrooesophageal reflux.

Authors:  M N Hartley; S J Walker; C R Mackie
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

6.  Gastro-oesophageal reflux in the irritable bowel syndrome.

Authors:  H L Smart; D A Nicholson; M Atkinson
Journal:  Gut       Date:  1986-10       Impact factor: 23.059

7.  Idiopathic autonomic denervation in eight patients presenting with functional gastrointestinal disease. A causal association?

Authors:  M Camilleri; R D Fealey
Journal:  Dig Dis Sci       Date:  1990-05       Impact factor: 3.199

8.  Effect of atropine on gastro-oesophageal reflux and transient lower oesophageal sphincter relaxations in patients with gastro-oesophageal reflux disease.

Authors:  I Lidums; H Checklin; R K Mittal; R H Holloway
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

9.  Relations among autonomic nerve dysfunction, oesophageal motility, and gastric emptying in gastro-oesophageal reflux disease.

Authors:  K M Cunningham; M Horowitz; P S Riddell; G J Maddern; J C Myers; R H Holloway; J M Wishart; G G Jamieson
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

10.  Abnormal cardiovascular reflexes in patients with gastro-oesophageal reflux.

Authors:  T K Chakraborty; A L Ogilvie; R C Heading; D J Ewing
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.